TRIP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.965800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.983600E-01
Normal-vs-Stage2
9.580400E-01
Normal-vs-Stage3
3.123800E-01
Normal-vs-Stage4
7.332400E-01
Stage1-vs-Stage2
6.608400E-01
Stage1-vs-Stage3
2.477600E-01
Stage1-vs-Stage4
4.450400E-01
Stage2-vs-Stage3
1.315800E-01
Stage2-vs-Stage4
6.548400E-01
Stage3-vs-Stage4
2.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.870200E-01
Normal-vs-AfricanAmerican
7.749600E-01
Normal-vs-Asian
6.970200E-01
Caucasian-vs-AfricanAmerican
7.565400E-01
Caucasian-vs-Asian
4.160400E-01
AfricanAmerican-vs-Asian
4.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.895600E-01
Normal-vs-Female
9.806400E-01
Male-vs-Female
8.873200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.912600E-01
Normal-vs-Age(41-60Yrs)
8.108000E-01
Normal-vs-Age(61-80Yrs)
9.097600E-01
Normal-vs-Age(81-100Yrs)
9.399000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.898400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.979800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.137800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.472200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.595000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.190200E-01
Normal-vs-Daily Drinker
7.970200E-01
Normal-vs-Weekly Drinker
7.011600E-01
Normal-vs-Occasional Drinker
4.673400E-01
Normal-vs-Social Drinker
6.229800E-01
Non Drinker-vs-Daily Drinker
7.026200E-01
Non Drinker-vs-Weekly Drinker
5.333200E-01
Non Drinker-vs-Occasional Drinker
1.606210E-01
Non Drinker-vs-Social Drinker
5.372200E-01
Daily Drinker-vs-Weekly Drinker
7.983400E-01
Daily Drinker-vs-Occasional Drinker
1.200160E-01
Daily Drinker-vs-Social Drinker
8.366800E-01
Weekly Drinker-vs-Occasional Drinker
1.297040E-01
Weekly Drinker-vs-Social Drinker
9.347600E-01
Occasional Drinker-vs-Social Drinker
4.092300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.532630E-01
Normal-vs-Grade 2
2.934400E-02
Normal-vs-Grade 3
3.200100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.550380E-01
Grade 1-vs-Grade 3
5.507600E-02
Grade 1-vs-Grade 4
1.532630E-01
Grade 2-vs-Grade 3
2.788000E-01
Grade 2-vs-Grade 4
2.934400E-02
Grade 3-vs-Grade 4
3.200100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.458400E-01
Normal-vs-NonDiabetic
9.893200E-01
Diabetic-vs-NonDiabetic
5.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.867600E-01
Normal-vs-NoPancreatitis
9.291800E-01
Pancreatitis-vs-NoPancreatitis
3.523800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.174200E-01
Normal-vs-N1
9.316800E-01
N0-vs-N1
4.941800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.092000E-01
Normal-vs-TP53-NonMutant
8.938800E-01
TP53-Mutant-vs-TP53-NonMutant
8.821900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
